RE:Answer to Q&A from VirtualInvestor PresentationA few others I missed:
I
s the 175M revenue trajectory more on the lighter side of 1 year? GC - We firmly believe with the balance sheet we have with 28m + 20m US credit line and the pipeline that the 175M run rate WOULD BE on the lighter side of 1 yr - post those transactions later in the year.
What other requirements for Nasdaq and NYSE listing: GC - 2 more requirements - expansion of board which they are actively looking and
a share consolidation when the timining is right sebraz wrote: Q&A:
Pace of acqusitions have been slow what is the plan?
GC- they have a full pipeline of acquisitions and should have an active 2021
How is your organic growth looking?
2019 they had organic growth of 9.6% and are looking to outpace that this year.
What are your plans for a tier 1 listing?
Just recently received DTC eligibility a few months ago with OTC listing. Believe they are in a good position to obtain a tier 1 listing in the US in 2021.